| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/ENE.13439 |
| P698 | PubMed publication ID | 28872215 |
| P50 | author | Christopher A Lane | Q58572127 |
| P2093 | author name string | J Hardy | |
| J M Schott | |||
| P433 | issue | 1 | |
| P304 | page(s) | 59-70 | |
| P577 | publication date | 2017-10-19 | |
| P1433 | published in | European Journal of Neurology | Q15757256 |
| P1476 | title | Alzheimer's disease | |
| P478 | volume | 25 |
| Q64967839 | A Glycosaminoglycan Extract from Portunus pelagicus Inhibits BACE1, the β Secretase Implicated in Alzheimer's Disease. |
| Q91895029 | A Network Pharmacology Approach to Reveal the Underlying Mechanisms of Paeonia lactiflora Pall. On the Treatment of Alzheimer's Disease |
| Q49556072 | A Systematic Review of Antiamyloidogenic and Metal-Chelating Peptoids: Two Structural Motifs for the Treatment of Alzheimer's Disease. |
| Q57030162 | A cross-species approach to disorders affecting brain and behaviour |
| Q92416887 | A novel rhamnoside derivative PL402 up-regulates matrix metalloproteinase 3/9 to promote Aβ degradation and alleviates Alzheimer's-like pathology |
| Q48104449 | ABCA7 and Pathogenic Pathways of Alzheimer's Disease. |
| Q89575981 | APOE-amyloid interaction: Therapeutic targets |
| Q99608983 | Abnormal Homocysteine Metabolism: An Insight of Alzheimer's Disease from DNA Methylation |
| Q90263988 | Accelerated Ovarian Failure as a Unique Model to Study Peri-Menopause Influence on Alzheimer's Disease |
| Q90697294 | Action of low doses of Aspirin in Inflammation and Oxidative Stress induced by aβ1-42 on Astrocytes in primary culture |
| Q64285109 | Adiponectin suppresses amyloid-β oligomer (AβO)-induced inflammatory response of microglia via AdipoR1-AMPK-NF-κB signaling pathway |
| Q90003697 | Ageing as a risk factor for neurodegenerative disease |
| Q97887374 | Alzheimer's Disease, Inflammation, and the Role of Antioxidants |
| Q89669785 | Alzheimer's disease: targeting the glutamatergic system |
| Q60530541 | Amyloid, tau, pathogen infection and antimicrobial protection in Alzheimer's disease -conformist, nonconformist, and realistic prospects for AD pathogenesis |
| Q49464422 | Application of Metabolomics in Alzheimer's Disease. |
| Q93039143 | Arginine π-stacking drives binding to fibrils of the Alzheimer protein Tau |
| Q64077439 | BACE-1 and γ-Secretase as Therapeutic Targets for Alzheimer's Disease |
| Q52325507 | Bacteroidetes Neurotoxins and Inflammatory Neurodegeneration. |
| Q90344542 | Benign Regulation of the Astrocytic Phospholipase A2-Arachidonic Acid Pathway: The Underlying Mechanism of the Beneficial Effects of Manual Acupuncture on CBF |
| Q64057721 | Blood amyloid-β oligomerization associated with neurodegeneration of Alzheimer's disease |
| Q99629113 | CMS121, a fatty acid synthase inhibitor, protects against excess lipid peroxidation and inflammation and alleviates cognitive loss in a transgenic mouse model of Alzheimer's disease |
| Q101237460 | Chia seeds as a potential cognitive booster in the APP23 Alzheimer's disease model |
| Q90478493 | Class C CpG Oligodeoxynucleotide Immunomodulatory Response in Aged Squirrel Monkey (Saimiri Boliviensis Boliviensis) |
| Q90374636 | Clinical Experience in Treatment of Alzheimer's Disease with Jiannao Yizhi Formula () and Routine Western Medicine |
| Q92856700 | Cofilin 2 in Serum as a Novel Biomarker for Alzheimer's Disease in Han Chinese |
| Q90050277 | Color Choice Preference in Cognitively Impaired Patients: A Look Inside Alzheimer's Disease Through the Use of Lüscher Color Diagnostic |
| Q89977186 | Contributions of DNA Damage to Alzheimer's Disease |
| Q90609511 | Current and emerging therapeutic targets of alzheimer's disease for the design of multi-target directed ligands |
| Q99637263 | DL0410 ameliorates cognitive disorder in SAMP8 mice by promoting mitochondrial dynamics and the NMDAR-CREB-BDNF pathway |
| Q98177411 | Default Mode Network Analysis of APOE Genotype in Cognitively Unimpaired Subjects Based on Persistent Homology |
| Q90272912 | Determining the mechanism behind yoga's effects on preventing the symptoms of Alzheimer's disease |
| Q90638271 | Dihydroartemisinin Ameliorates Learning and Memory in Alzheimer's Disease Through Promoting Autophagosome-Lysosome Fusion and Autolysosomal Degradation for Aβ Clearance |
| Q89871685 | Direct Activation of Protein Phosphatase 2A (PP2A) by Tricyclic Sulfonamides Ameliorates Alzheimer's Disease Pathogenesis in Cell and Animal Models |
| Q91607278 | Diversity in Aβ deposit morphology and secondary proteome insolubility across models of Alzheimer-type amyloidosis |
| Q91707000 | Dreaming of a New World Where Alzheimer's Is a Treatable Disorder |
| Q101051196 | Dynamic changes in the brain protein interaction network correlates with progression of Aβ42 pathology in Drosophila |
| Q91867181 | Dysfunctional Mitochondria and Mitophagy as Drivers of Alzheimer's Disease Pathogenesis |
| Q92898624 | Effects of Huang-Lian-Jie-Du Decoction on Oxidative Stress and AMPK-SIRT1 Pathway in Alzheimer's Disease Rat |
| Q55379242 | Emerging Biosensing Technologies for Neuroinflammatory and Neurodegenerative Disease Diagnostics. |
| Q91785258 | Endophilin 1 knockdown prevents synaptic dysfunction induced by oligomeric amyloid β |
| Q91894190 | Evidence for Decreased Nucleolar PARP-1 as an Early Marker of Cognitive Impairment |
| Q64098830 | Exposure to fluoride aggravates the impairment in learning and memory and neuropathological lesions in mice carrying the APP/PS1 double-transgenic mutation |
| Q90340437 | GAPT regulates cholinergic dysfunction and oxidative stress in the brains of learning and memory impairment mice induced by scopolamine |
| Q90134684 | Genetic Ablation of Hematopoietic Cell Kinase Accelerates Alzheimer's Disease-Like Neuropathology in Tg2576 Mice |
| Q90707560 | Gold Nanoparticles Treatment Reverses Brain Damage in Alzheimer's Disease Model |
| Q98612727 | Helicobacter pylori infection: Beyond gastric manifestations |
| Q94453564 | High incidence of dementia in Faroese-born female residents in Denmark |
| Q55365163 | Immunotherapy to improve cognition and reduce pathological species in an Alzheimer's disease mouse model. |
| Q99712930 | Influence of Woodsmoke Exposure on Molecular Mechanisms Underlying Alzheimer's Disease: Existing Literature and Gaps in Our Understanding |
| Q112337950 | Inhibiting Autophagy Pathway of PI3K/AKT/mTOR Promotes Apoptosis in SK-N-SH Cell Model of Alzheimer's Disease |
| Q93047838 | Inhibition of BACE1, the β-secretase implicated in Alzheimer's disease, by a chondroitin sulfate extract from Sardina pilchardus |
| Q89736078 | Iron Metabolism, Ferroptosis, and the Links With Alzheimer's Disease |
| Q91710089 | Islet Amyloid Polypeptide: A Partner in Crime With Aβ in the Pathology of Alzheimer's Disease |
| Q89493870 | Kaixinsan, a Well-Known Chinese Herbal Prescription, for Alzheimer's Disease and Depression: A Preclinical Systematic Review |
| Q93062193 | Ketone Bodies in Neurological Diseases: Focus on Neuroprotection and Underlying Mechanisms |
| Q96643024 | Knockdown of long non-coding RNA TUG1 depresses apoptosis of hippocampal neurons in Alzheimer's disease by elevating microRNA-15a and repressing ROCK1 expression |
| Q89743983 | Ligustilide improves aging-induced memory deficit by regulating mitochondrial related inflammation in SAMP8 mice |
| Q92556229 | LncRNAs related key pathways and genes in ischemic stroke by weighted gene co-expression network analysis (WGCNA) |
| Q90636107 | Long-Term Dabigatran Treatment Delays Alzheimer's Disease Pathogenesis in the TgCRND8 Mouse Model |
| Q96136443 | Low vision and the risk of dementia: a nationwide population-based cohort study |
| Q92989541 | Metabolic Brain Network Analysis of FDG-PET in Alzheimer's Disease Using Kernel-Based Persistent Features |
| Q89992960 | Metabolic and amyloid PET network reorganization in Alzheimer's disease: differential patterns and partial volume effects |
| Q92703346 | Mfn2 Ablation in the Adult Mouse Hippocampus and Cortex Causes Neuronal Death |
| Q92669442 | MicroRNA-298 reduces levels of human amyloid-β precursor protein (APP), β-site APP-converting enzyme 1 (BACE1) and specific tau protein moieties |
| Q99711177 | MicroRNAs in Alzheimer's Disease: Function and Potential Applications as Diagnostic Biomarkers |
| Q99578893 | Microglia TREM2: A Potential Role in the Mechanism of Action of Electroacupuncture in an Alzheimer's Disease Animal Model |
| Q99711218 | Mitochondrial Dysfunction and Alzheimer's Disease: Role of Microglia |
| Q91782721 | Nasal delivery of a CRMP2-derived CBD3 adenovirus improves cognitive function and pathology in APP/PS1 transgenic mice |
| Q92814294 | Neurofilaments: The C-Reactive Protein of Neurology |
| Q91827638 | Neuroprotective Effect of S-trans, Trans-farnesylthiosalicylic Acid via Inhibition of RAS/ERK Pathway for the Treatment of Alzheimer's Disease |
| Q92654761 | Neuroprotective effect of CPCGI on Alzheimer's disease and its mechanism |
| Q90224969 | New Insights on the Role of Manganese in Alzheimer's Disease and Parkinson's Disease |
| Q91750984 | Omics-based Biomarkers for the Early Alzheimer Disease Diagnosis and Reliable Therapeutic Targets Development |
| Q98288728 | Pathological Mechanisms Linking Diabetes Mellitus and Alzheimer's Disease: the Receptor for Advanced Glycation End Products (RAGE) |
| Q88121156 | Pathologically Confirmed Alzheimer's Disease in APOE ɛ2 Homozygotes is Rare but Does Occur |
| Q96155773 | Peptidyl-Prolyl Cis/Trans Isomerase Pin1 and Alzheimer's Disease |
| Q89644749 | Peripheral inflammation promotes brain tau transmission via disrupting blood-brain barrier |
| Q90520372 | Pharmacological Mechanisms Underlying the Neuroprotective Effects of Alpinia oxyphylla Miq. on Alzheimer's Disease |
| Q92599729 | Pharmacological Targets and the Biological Mechanisms of Formononetin for Alzheimer's Disease: A Network Analysis |
| Q92354226 | Phosphorylation Signaling in APP Processing in Alzheimer's Disease |
| Q96302485 | Prenatal exposure to bisphenol A alters the transcriptome-interactome profiles of genes associated with Alzheimer's disease in the offspring hippocampus |
| Q89662011 | Presenilin1 exerts antiproliferative effects by repressing the Wnt/β-catenin pathway in glioblastoma |
| Q89975356 | Protein Kinase C Isozymes and Autophagy during Neurodegenerative Disease Progression |
| Q60052985 | Rare genetic variation implicated in non-Hispanic white families with Alzheimer disease |
| Q92989320 | Red Ginseng Attenuates Aβ-Induced Mitochondrial Dysfunction and Aβ-mediated Pathology in an Animal Model of Alzheimer's Disease |
| Q92527693 | Regulation of Brain Cholesterol: What Role Do Liver X Receptors Play in Neurodegenerative Diseases? |
| Q99414763 | Regulation of blood-brain barrier integrity by microglia in health and disease: A therapeutic opportunity |
| Q89287870 | Resveratrol Induces Brain Resilience Against Alzheimer Neurodegeneration Through Proteostasis Enhancement |
| Q97066898 | Retinal and Brain Organoids: Bridging the Gap Between in vivo Physiology and in vitro Micro-Physiology for the Study of Alzheimer's Diseases |
| Q90399865 | Role of Neurofilament Light Chain as a Potential Biomarker for Alzheimer's Disease: A Correlative Meta-Analysis |
| Q92824866 | Role of miRNAs in Alzheimer's Disease and Possible Fields of Application |
| Q93087837 | Roles of Neuropeptide Y in Neurodegenerative and Neuroimmune Diseases |
| Q96303198 | Safety and Efficacy of 630-nm Red Light on Cognitive Function in Older Adults With Mild to Moderate Alzheimer's Disease: Protocol for a Randomized Controlled Study |
| Q91651799 | Secernin-1 is a novel phosphorylated tau binding protein that accumulates in Alzheimer's disease and not in other tauopathies |
| Q53398026 | Spore powder of Ganoderma lucidum for the treatment of Alzheimer disease: A pilot study. |
| Q99212853 | Systems-based proteomics to resolve the biology of Alzheimer's disease beyond amyloid and tau |
| Q90296581 | Targeting Iron Dyshomeostasis for Treatment of Neurodegenerative Disorders |
| Q90398264 | Tauopathy Analysis in P301S Mouse Model of Alzheimer Disease Immunized With DNA and MVA Poxvirus-Based Vaccines Expressing Human Full-Length 4R2N or 3RC Tau Proteins |
| Q90564396 | The Challenge to Search for New Nervous System Disease Biomarker Candidates: the Opportunity to Use the Proteogenomics Approach |
| Q91813792 | The Drosophila Model: Exploring Novel Therapeutic Compounds against Neurodegenerative Diseases |
| Q92062254 | The Predicted Key Molecules, Functions, and Pathways That Bridge Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD) |
| Q99711200 | The Reversal of Memory Deficits in an Alzheimer's Disease Model Using Physical and Cognitive Exercise |
| Q55294882 | The Role of Immunosenescence in Neurodegenerative Diseases. |
| Q92637631 | The Role of Macrophage Migration Inhibitory Factor in Alzheimer's Disease: Conventionally Pathogenetic or Unconventionally Protective? |
| Q89698133 | The Role of Periodontitis and Periodontal Bacteria in the Onset and Progression of Alzheimer's Disease: A Systematic Review |
| Q92535704 | The Use of Antipsychotic Drugs for Treating Behavioral Symptoms in Alzheimer's Disease |
| Q92374124 | The neuropathological diagnosis of Alzheimer's disease |
| Q89464800 | The neuroprotective effects of SIRT1 in mice carrying the APP/PS1 double-transgenic mutation and in SH-SY5Y cells over-expressing human APP670/671 may involve elevated levels of α7 nicotinic acetylcholine receptors |
| Q64890986 | The protective effects of polyphenols on Alzheimer's disease: A systematic review. |
| Q92537416 | Therapeutic Applications of Cysteamine and Cystamine in Neurodegenerative and Neuropsychiatric Diseases |
| Q96431687 | Three-dimensional real time imaging of amyloid β aggregation on living cells |
| Q94544697 | Traditional Chinese Medicine: Role in Reducing β-Amyloid, Apoptosis, Autophagy, Neuroinflammation, Oxidative Stress, and Mitochondrial Dysfunction of Alzheimer's Disease |
| Q90723317 | Transcriptional Networks of Microglia in Alzheimer's Disease and Insights into Pathogenesis |
| Q88913521 | Umbilical Cord Mesenchymal Stem Cells Conditioned Medium Promotes Aβ25-35 phagocytosis by Modulating Autophagy and Aβ-Degrading Enzymes in BV2 Cells |
| Q104070098 | Up-regulation of miRNA-151-3p enhanced the neuroprotective effect of dexmedetomidine against β-amyloid by targeting DAPK-1 and TP53 |
| Q99585428 | Using Mendelian randomization to understand and develop treatments for neurodegenerative disease |
| Q58567916 | Visual Features in Alzheimer's Disease: From Basic Mechanisms to Clinical Overview |
| Q95270302 | Yizhi Qingxin Formula Extract Ameliorates Cognitive Decline in Aged Rats via the Brain-Derived Neurotrophic Factor/Tropomyosin Receptor Kinase B Pathway |
| Q92632808 | pH-Dependent Aggregation in Intrinsically Disordered Proteins Is Determined by Charge and Lipophilicity |
| Q97423413 | β-amyloid and tau drive early Alzheimer's disease decline while glucose hypometabolism drives late decline |
Search more.